Clinical Trials
66 trialsLIBRETTO-001
Eli Lilly and Company
AcceleRET-Lung
Hoffmann-La Roche
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
LIBRETTO-121
Eli Lilly and Company
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
Shasqi, Inc.
GLIMMER-01
Palleon Pharmaceuticals, Inc.
Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy
University of Michigan
The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial
Icahn School of Medicine at Mount Sinai
IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma
University of California, San Diego
DEHART
Medical College of Wisconsin
ARROW
Hoffmann-La Roche
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
Numab Therapeutics AG
Meteor 1
GlaxoSmithKline
IT-01
Intensity Therapeutics, Inc.
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
Atara Biotherapeutics
A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer
Mural Oncology, Inc
GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors
GlaxoSmithKline
INDUCE-3
GlaxoSmithKline
Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer
Massachusetts General Hospital
INSPIRE
Brooklyn ImmunoTherapeutics, LLC
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
CytomX Therapeutics
Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers
Novartis
ALpha-T
Hoffmann-La Roche
A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer
Advaxis, Inc.
A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN
University of Kentucky
PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)
Amgen
Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer
MedImmune LLC
Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer
Fox Chase Cancer Center
Brain Stimulation For Cancer Smokers
Medical University of South Carolina
Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Pfizer
E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck
Eisai Inc.
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)
EMD Serono
Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery
University of California, Davis
A Study of AK-01 (LY3295668) in Solid Tumors
Eli Lilly and Company
Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study
First Affiliated Hospital of Harbin Medical University
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
Bayer
MK-1697-001
Merck Sharp & Dohme LLC
NDURE
Medical University of South Carolina
A Randomized Study of Sulindac in Oral Premalignant Lesions
Memorial Sloan Kettering Cancer Center
A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel
Daiichi Sankyo
A Pilot Study to Evaluate the Feasibility and Potential Effectiveness of the Flexitouch System Head and Neck Treatment
Tactile Medical
Imaging Study for FdCyd and THU Cancer Treatment
National Institutes of Health Clinical Center (CC)
Preoperative Treatment With Cetuximab and/or IMC-A12
M.D. Anderson Cancer Center
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
Case Comprehensive Cancer Center
EPIC
University of Chicago
Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer
University of Arizona
Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema
Tactile Medical
Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma
Celgene
A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)
National Institutes of Health Clinical Center (CC)
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Amgen